Work

Assessment of the health-related quality of life impact of Euflexxa® (1% sodium hyaluronate) using the short form (SF)-36 data collected in a randomized clinical trial

Year: 2013

Type: article

Source: Osteoarthritis and Cartilage

DOI: 10.1016/j.joca.2013.02.505

Authors: H.T. Hatoum, J.E. Rosen, A.L. Fierlinger, S.-J. Lin, R.D. Altman

Institutions: University of Illinois Chicago, New York Hospital Queens, Ferring Pharmaceuticals (United States), University of California, Los Angeles

Language: English

Topic: Osteoarthritis Treatment and Mechanisms

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2332977412

FWCI: 0.224

Cites:

Cited by: 3

Related to: 10